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Abstract—The r e l a t i v e b i o l o g i c a l effectiveness has been c o m p a r e d f o r ten n e u t r o n f a c i l i t i e s used 
f o r c l i n i c a l r a d i o t h e r a p y i n the U n i t e d States, J a p a n , C o n t i n e n t a l E u r o p e a n d G r e a t B r i t a i n . 
M a m m a l i a n c e l l s i n c u l t u r e were used a n d i n o r d e r t o e x p l o i t the p r e c i s i o n of w h i c h the in vitro 
technique is c a p a b l e , f a c i l i t i e s were i n t e r c o m p a r e d i n p a i r s , w i t h i n a given experiment on the same 
day. Tables a r e presented of the r e l a t i v e potency o f the v a r i o u s n e u t r o n beams. D e t e r m i n a t i o n s of 
the oxygen enhancement r a t i o n ( O E R ) have been made f o r a w i d e ränge of neutrons p r o d u c e d by 
c y c l o t r o n s o r l i n e a r a c c e l e r a t o r s u s i n g the deuteron o r p r o t o n on b e r y l l i u m r e a c t i o n s . The OER 
increases w i t h i n c r e a s i n g energy of the c h a r g e d p a r t i c l e used f r o m 1.5 f o r 15 M e V d + - > B e t o 1.9 
f o r 101 M e V p + - > B e . F o r a c l i n i c a l l y used 1 4 - M e V d^-^Tgenerator the OER was f o u n d t o be 
1.6. 
Introduction 
The clinical trial of neutrons involves a 
substantial cost and investment of effort. 
Consequently, the need for füll Cooperation 
between the few centers using these particles has 
been recognized from the outset. Each of the 
neutron therapy beams in clinical use is 
characterized by a different energy spectrum, 
and as a consequence there are significant 
variations in their biological effectiveness. To 
facilitate the pooling of experience and the 
comparison of clinical results a number of 
investigators have compared the various neutron 
beams using a variety of biological Systems, and 
early results have already been published (Hall, 
1977; Hall et al, 1978). The present report 
summarizes the results of a new series of 
biological intercomparisons performed by three 
groups of investigators using mammalian cells 
cultured in vitro. 
The design of these experiments was based 
upon two important considerations. 
(a) It is a characteristic of cell-culture 
experiments that variations w i t h i n an experiment 
are much smaller than those between 
experiments. Consequently, to exploit the 
precision of which the in vitro technique is 
capable, neutron facilities were intercompared in 
pairs, within a given experiment, using cells from 
a common culture irradiated on the same day. 
(b) A standardized treatment fixture was used 
'Based on work performed under Contract EP-78-S-02-< 
Number CA-18506 awarded by the National Cancer Instit 
at all facilities, constructed of lucite, with space 
for six tissue culture flasks, and provision for an 
ionization Chamber to be inserted into the jig to 
determine the dose received at the position 
occupied by the cells. Füll build-up was ensured 
because the cells were overlaid with 2 cm of 
tissue culture medium. A substantial 
international effort to achieve compatible 
dosimetry was mounted by the physicists at the 
various installations engaged in neutron therapy, 
as a consequence of which there is agreement to 
within + 1.5% for dose measurements in air. The 
use of the Standard treatment fixture was an 
attempt to extend the compatible dosimetry to a 
practical set-up for the irradiation of cell 
cultures. 
RBE intercomparison 
The neutron facilities visited, together with 
their principal characteristics, are listed in Table 
1. For the most part, this paper will be concerned 
with our own experiments in the United States, 
Japan, Britain and Continental Europe, in which 
Chinese hamster V79 cells were used for R B E 
intercomparisons. In a typical experiment, 
appropriate numbers of cells were plated into 
Falcon tissue culture flasks and allowed to attach 
by overnight incubation at 37.5°C. The flasks 
were then filled brimful with medium, sealed, and 
the temperature lowered to 17°C. For each 
\3 from the United States Department of Energy, and Grant 
J, Department of Health, Education and Weifare. 
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T a b l e 1. C l i n i c a l n e u t r o n f a c i l i t i e s i n t e r c o m p a r e d 
Facility Location 
U . S . A . 
U . K . 
Netherlands 
Japan 
Energy of Mean 
Fermilab Batavia Production accelerated neutron 
Illinois process particle energy 
Tamvec College (MeV) (MeV) 
Station, 
Texas p +->Be 66 25 
N R L / M a n t a Washington, 
D . C . d + - B e 50 19.3 
N A S A / G l a n t a Cleveland, 
Ohio d + - B e 35 14.3 
Univ. Wash. Seattle, 
Wash. d+->Be 25 10 
1 M R C , Hammersmith London d + -*Be 22 8 
[ M R C , Edinburgh Edinburgh 
d +-+Be 16 7 
Antoni van d + - B e 15 6 
Leuwenhoek Amsterdam 
Hospital d + - T — 14 
J N I R S Chiba d+->Be 30 12 
J I M S Tokyo d + - B e 15 6 
experiment, half of the flasks were transported to 
the Naval Research Laboratory ( N R L ) 
cyclotron in Washington, D . C , and half to one 
of the other facilities listed in Table 1. The cells 
were transported in insulated water-jacketed 
carriers, with the temperature maintained at 
17°C. It was found by trial and error that this 
temperature prevents cell division and 
progression through the cycle, while maintaining 
a high plating efficiency (which was 
characteristically in excess of 80%) for a period 
of 24 hours. Irradiations were performed 
simultaneously at the two neutron facilities to be 
compared, and the cells returned to an incubator 
for 8 days to assess the proportion able to form 
colonies. 
1 20 
MEAN N E U R O N E N E ^ G V (VeV) 
F i g . 1. The r e l a t i v e potency, o r R B E r e l a t i v e t o t h e N a v a l 
Research L a b o r a t o r y , as a f u n c t i o n of mean n e u t r o n 
energy, f o r v a r i o u s f a c i l i t i e s i n c l i n i c a l use. 
The data from each experiment were analysed 
by a new non-parametric method, which evokes 
no form for the dose-response relationship. The 
survival data for the two neutron beams to be 
compared were fitted by curves of the same 
shape, the only constraint being that the curve 
must be convex upwards, and the dose factor 
necessary to allow a common fit computed. This 
factor is then the best estimate of the relative 
potency or R B E difference between the two 
beams, based on the data from all dose levels 
studied. The results are shown in Fig. 1; the 
potency of each beam relative to N R L is plotted 
as a function of the mean neutron energy. The 
data points for accelerators using the rf+->Be 
reaction fall close to a common line indicating a 
gradually increasing R B E with decreasing mean 
neutron energy. 
The data are summarized in a way that is more 
widely useful in Table 2, which consists of 
factors relating the RBE's between pairs 
of machines. This table also includes a summary 
of data collected by two other investigators. Dr. 
Paul Todd, Pennsylvania State University, has 
used Tj cells of human kidney origin to inter-
compare a number of neutron beams in clinical 
use. Dr. Raymond Meyn, M . D . Anderson 
Hospital, Houston, Texas, used C H O cells for 
intercomparisons. The details of the 
experimental methods used by these 
investigators have been published previously 
(Gragg et al.9 1976; Todd et al.9 1978). Both 
utilized a standardized treatment fixture and 
most of their recent experiments were designed 
so that pairs of machines were compared on the 
same day within the same experiment, though 
this was not true of earlier studies. The potency 
factors quoted were calculated at a cell survival 
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T a b l e 2. R e l a t i v e potency of v a r i o u s beams i n t e r c o m p a r e d 
The numbers quoted represent the dose (in Gray) necessary with the facility in the left-hand 
column to be equivalent to 1 Gray with the facility in the top row. (In each Square, the top figure is 
due to E. J. Hall, the middle to Paul Todd and the lower to Raymond Meyn.) 
IMS Edin. Harn. Amst. U.W. Clev. N I R S N R L Tarn. Fermi 
IMS * — — — 0.96 — 0.82 0.84 — — 
1.00 0.95 0.95 0.95 0.91 0.90 0.86 0.82 
Edin. — 
— 1.00 0.95 0.95 0.95 0.91 0.90 0.86 0.82 
Harn. — — * — — — — — — — 
— — — 0.85 0.88 0.76 0.77 0.72 0.84 
— 1.06 1.06 1.00 1.01 0.95 0.95 0.90 0.87 
Amst. — — — * — — — — — — 
1.06 1.06 1.00 1.01 0.96 0.95 0.90 0.87 
U . W . 1.04 — — — — 0.85 0.99 — — 
— — 1.18 — 1.04 0.89 0.91 0.85 0.99 
— 1.05 1.05 0.99 0.99 — 0.95 0.94 0.90 0.86 
Clev. — — — — — * — 0.95 — — 
— — 1.13 — 0.96 0.85 0.87 0.81 0.95 
— 1.10 1.10 1.04 1.04 1.05 1.00 0.95 0.91 
NIRS 1.22 — — — 1.18 — * 1.00 — — 
— — 1.32 — 1.12 1.17 1.02 0.95 1.11 
— 1.11 1.11 1.05 1.05 1.06 1.005 0.95 0.91 
N R L 1.19 — — — 1.01 1.05 1.00 * — — 
— — 1.30 — 1.10 1.15 0.98 0.93 1.09 
— 1.17 1.17 1.11 1.11 1.12 1.06 1.05 0.96 
Tarn. * — 
— — 1.39 — 1.18 1.23 1.05 1.07 1.17 
— 1.22 1.22 1.15 1.15 1.16 1.10 1.10 1.04 
Fermi. * 
— — 1.19 — 1.01 1.05 0.90 0.91 0.85 
level of 0.3. In all cases, comparisons have been 
made on the basis of T O T A L D O S E , i.e. neutron 
and gamma-ray dose. For the European 
machines, consisting of a d + ->T generator and 
two lower-energy cyclotrons, the gamma-ray 
contribution is both larger and more variable 
than for the higher-energy installations in the 
United States. 
It can be seen from Table 2 that there is, in 
general, close agreement between the three sets 
of measurements regarding potency ratios, or 
R B E differences, between the various neutron 
beams used clinically. This is particularly true for 
inter-comparisons between machines within the 
United States and also for NIRS in Japan. This 
reflects the greatest effort that has been made to 
date. By contrast, few direct Transatlantic 
intercomparisons have so far been completed. 
The title of this paper indicates that its scope is 
restricted to in vitro data. However, recent 
reports (Hall et al.91978) have summarized R B E 
intercomparisons performed with in vivo 
Systems, such as skin and jejunal crypt cells in 
mice, as well as for various cultured mammalian 
cells. The closeness of the agreement observed 
bears out the Suggestion made in the Part II 
meeting (Hall, 1977) that for intercomparing two 
neutron beams that differ in energy by only a 
modest amount, it matters little which biological 
System is chosen. Systems and endpoints which 
result in widely different values for the R B E of 
neutrons relative to X-rays give similar values 
for the R B E dijference between two closely 
related neutron energies. Consequently, the 
choice of a biological System for inter-
comparisons should be governed largely by its 
portability, repeatability and convenience. 
OER survey 
No review of neutron data for cells in culture 
would be complete without reference to values 
obtained for the oxygen enhancement ratio 
(OER). Düring the past 2 years a Standard 
biological technique has been used to determine 
the O E R for neutron beams generated by the 
d+->Be or p + -•Be processes, where the energy 
of the accelerated charged particle has ranged 
from 15 to 101 MeV. For these experiments 
hamster V79 cells were used and hypoxia 
produced by crowding a large number of cells 
into a small volume so that oxygen was 
consumed by respiration (Hall et al., 1974). The 
results are shown in Fig. 2. There appears to be a 
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BROOKHAVEN 
Sca t te r - f ree 
AMSTERDAM 
Col l imated 
E N E R G Y O F D E U T E R O N O R P R O T O N ( m e V ) 
I N C I D E N T O N B E R Y L I U M T A R G E T 
* 
F i g . 2. Values o f the oxygen enhancement r a t i o ( O E R ) f o r v a r i o u s n e u t r o n beams p r o d u c e d by the 
p + Be, o r d + - > T r e a c t i o n s . Experiments a t the U n i v e r s i t y of M a r y l a n d a t 80 M e V were repeated 
w i t h a t h i c k b e r y l l i u m t a r g e t a n d w i t h a t h i n Be a n d A I t a r g e t ; the l a t t e r r e s u l t e d i n a n e u t r o n 
spectrum w i t h a h i g h e r mean energy. 
continuous increase in O E R with mean neutron 
energy, and our experience does not confirm the 
lower O E R at high neutron energies previously 
reported (Harrison et a l 1975, 1976). Using the 
same biological System, it has been shown also 
that a collimated beam of neutrons from the 
d + -> T generator at Amsterdam is characterized 
by an OER equal to that of the clinically used 
cyclotrons in the United States. The value 
obtained, however, is significantly lower than the 
O E R previously reported for 14 MeV d+->T 
neutrons in a scatter free environment. 
Acknowledgements-The implementation of this project 
was totally dependent upon the Cooperation and dedication 
of the staff at the various neutron facilities where 
experiments were performed. Special thanks are due to 
Drs. D . Bewley, J. Parnell and S. B. Field at the 
Hammersmith Hospital, London; Dr. Peter Bonnett at the 
Western General Hospital, Edinburgh; Drs. B. J. Mijnheer 
and K . Breur at the Antoni van Leeuwenhoek Hospital, 
Amsterdam; Drs. J. Broerse and G . W. Barendsen at the 
Radiobiological Institute T N O , The Netherlands; Drs. K . 
Misonon, H . Ohara, T. Inada, K . Kawashima and Dr. 
Umegaki at NIRS , Chiba; Dr. S. Suzuki at IMS, Tokyo; 
Drs. Richard Theus, Leon August, and P. Shapiro at the 
Naval Research Laboratory, Washington, D . C ; Dr. Juri 
Eenmaa at the University of Washington, Seattle; Dr. 
James Smathers at the Texas A & M Variable Energy 
Cyclotron, College Station, Texas; Dr. Miguel Awschalom 
at the Fermilab, Batavia, Illinois; Drs. Horton and R. 
Antunez of the Cleveland Clinic. 
References 
G R A G G , R. L . , R. M . H U M P H R E Y and R. M E Y N ( 1 9 7 6 ) 
The response of Chinese hamster ovary cells to fast 
neutron radiotherapy beams. 1. Relative biological 
effectiveness and oxygen enhancement ratio. 
Radiat.Res. 65,71-82. 
H A L L , E. J. (1977) Radiobiological intercomparison i n 
v i v o and i n v i t r o . P r o c o f P a r t i c l e s a n d R a d i a t i o n 
Therapy Second I n t e r n a t i o n a l Conference. I n t . J. 
R a d i a t . O n c o l . B i o l . Phys. 3.195-201. 
H A L L , E. J., S. L E H N E R T and L . R O I Z I N - T O W L E (1974) 
Split-dose experiments with hypoxic cells. 
R a d i o l o g y 112,425-430. 
H A L L , E. J., H . R. W I T H E R S , J. P. G E R A C I , R. E. M E Y N , 
J. R A S E Y , P. T O D D and G . E. S H E L I N E (1978) 
Radiobiological intercomparisons of fast neutron 
beams used for therapy in Japan and the United 
States. I n t . J. R a d i a t . O n c o l . B i o l . Phys. (in press). 
H A R R I S O N , G . H . , E. B . K U B I C Z E K and J. E. R O B I N S O N 
(1975) O E R of neutrons from 80 M e V deuterons on 
beryllium. B r i t . J. R a d i o l . 48,409-410. 
H A R R I S O N , G . H . , E. B . K U B I C Z E K and J. E. R O B I N S O N 
(1976) O E R reductions with high-energy neutrons. 
B r i t . J. R a d i o l . 49,733. 
T O D D , P., J. P. G E R A C I , P. S. F U R C I N I T T I , R. M . R O S S I , 
F . M I K A G E , R. T H E U S and C. B . S C H R O Y (1978) 
Comparison of the effects of various cyclotron-
produced fast neutrons on the reproductive capacity 
of cultured human kidney (T-l) cells. I n t . J. R a d i a t . 
O n c o l . B i o l . Phys. ( i n press). 
